Raj Medico

Abevmy Injection (bevacizumab biosimilar) is a cutting-edge, anti-cancer biologic designed to inhibit the growth of tumors by blocking vascular endothelial growth factor (VEGF)—thereby reducing the blood supply that tumors need to survive and grow. 

Abevmy is approved for use in adults, in combination with specific chemotherapy regimens, for the treatment of:

• Metastatic Colorectal Cancer in combination with fluoropyrimidine-based chemotherapy

• Metastatic Breast Cancer – first-line therapy with paclitaxel (for patients ineligible for anthracycline regimens)

• Advanced or Recurrent Non-Small Cell Lung Cancer (Non-Squamous) – in combination with platinum-based chemotherapy, and with erlotinib for EGFR mutation-positive cases

• Advanced or Metastatic Renal Cell Carcinoma – combined with interferon alfa-2a

• Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer – both front-line and recurrent (platinum-resistant and -sensitive) settings

• Persistent, Recurrent, or Metastatic Cervical Cancer – with paclitaxel plus cisplatin or topotecan alternatives

• Glioblastoma (Grade IV Malignant Glioma) – as monotherapy after relapse or progression

As a biosimilar to Avastin, Abevmy is a recombinant monoclonal antibody that binds selectively to VEGF, neutralizing its effect. This anti-angiogenic action restricts tumor blood vessel formation, starving cancer cells of oxygen and nutrients and inhibiting growth

• Route: Intravenous infusion administered in a clinical or hospital setting.

•  

• Common Side Effects: Hypertension, headaches, nosebleeds, diarrhea, proteinuria, fatigue, abdominal pain

• Serious Risks: Gastrointestinal perforation, hemorrhage, arterial thromboembolism, impaired wound healing

• Special Warnings:

  • Avoid in pregnancy or nursing—Abevmy can harm the unborn or nursing child.

  • Discontinue at least 28 days before major surgery to reduce wound-healing complications.

  • Monitor blood pressure, proteinuria, and bleeding risks during treatment.

  • Use with caution in elderly patients (≥65 years) and contraindicated in children (<18 years).

• Abevmy Injection

• Abevmy bevacizumab biosimilar

• Abevmy cancer treatment

• Abevmy indications

• Abevmy dosage and side effects

• Buy Abevmy Injection online

Canmab Injection (Trastuzumab) is a monoclonal antibody therapy used in the treatment of HER2-positive breast cancer and gastric cancer. It works by selectively binding to the HER2 receptor, blocking signals that promote cancer cell growth and survival. Canmab Injection is widely prescribed in both early-stage and metastatic breast cancer, either as monotherapy or in combination with chemotherapy.

Manufactured with world-class pharmaceutical standards, Canmab is trusted by oncologists for its efficacy, safety, and consistent clinical outcomes.

• Effective therapy for HER2-positive breast and gastric cancer

• Helps inhibit tumor growth and spread by targeting HER2 receptors

• Can be used alone or with chemotherapy and other cancer treatments

• Improves treatment response and patient survival

• Well-researched, with proven global clinical results

• Administered via intravenous infusion under medical supervision.

• Dosage and treatment schedule are determined by the oncologist based on the patient’s condition and cancer stage.

• Requires regular monitoring of heart function and overall health during treatment.

• To be used only with a valid doctor’s prescription.

• Not suitable for patients with a history of severe heart disease.

• Possible side effects: fever, chills, weakness, headache, nausea, diarrhea, and infusion-related reactions.

• Long-term therapy requires regular cardiac evaluations.

• Canmab Injection

• Canmab Trastuzumab

• Canmab Injection uses

• Canmab for HER2-positive breast cancer

• Buy Canmab Injection online

• Canmab Injection dosage and side effects

• Trastuzumab injection for breast cancer

• Targeted therapy for HER2-positive gastric cancer

Hertraz 440mg is a prescription medicine containing Trastuzumab, a monoclonal antibody used primarily in the treatment of HER2-positive breast cancer and gastric cancer. Manufactured by Mylan, Hertraz works by targeting and inhibiting the HER2 receptor, helping to slow or stop the growth of cancer cells.

At Raj Medico, we provide authentic, well-stored, and quality-assured oncology medications like Hertraz 440mg at competitive prices. Our licensed pharmacists ensure timely delivery and support for cancer care needs.

Key Details:

• Brand Name: Hertraz 440mg

• Generic Name: Trastuzumab

• Manufacturer: Mylan Pharmaceuticals

• Strength: 440mg

• Form: Injection

• Use: Treatment of HER2-positive breast and gastric cancers

• Prescription Required: Yes

Why Choose Raj Medico?

• Trusted source for oncology and specialty medicines

• Nationwide delivery

• 100% genuine products

• Customer support for dosage and usage guidance

• Sterile Single Dose Vial
• Lyophilized 
• Dosage: As directed by the Physician
• Keep out of reach of children
• Store below 25 degree C
• Do not use if vial seal is broken
• Warning: Cytotoxic Agent, To be supplied on demand from Cancer Hospital, Institutions and on prescription of an Oncologist only.

• r-DNA origin
• For IV Infusion
• Multi use vial
• Lyophilized Powder
• Reliance Trastuzumab For Injection + Bacteriostatic water for Injection USP 20 ml-Combokit

• Each pack contains 1 vial of Lyophilized Powder of Trastuzumab, 1 vial with 20 ml Sterile Bacteriostatic water for injection and package insert.
• Dosage: As directed by the physician
• Keep out of reach of childre
• Not to be sold by retail without the prescription of an Medical Oncologist.

• Lyophilized Powder
• To be diluted for I.V. Infusion
• Dosage: As directed by the Physician
• Keep out of reach of children
• Store at 15 - 25 degree C
• Do not refrigerate
• Do not use if vial seal is broken
• Warning: Cytotoxic Agent, To be supplied on demand from Cancer Hospital, Institutions and on prescription of an Oncologist only.

• r-DNA origin
• For I.V. Infusion, multiple use vial
• Lyophilized Powder
• 1 vial of Trastuzumab / 2 vial of BWFI

• Protein Bound Particles
• Lyophilized Powder For Suspension For Infusion
• Sterile Single Use Vial
• For Intravenous Use Only
• For sale in India only

• Sterile Single Dose Vial
• Lyophilized
• Dosage: As directed by the Physician
• Keep out of reach of children
• Store below 25 degree C
• Do not use if vial seal is broken
• Warning: Cytotoxic Agent, To be supplied on demand from Cancer Hospital, Institutions and on prescription of an Oncologist only.

• Store at 2 to 8 degree C
• As directed by the Physician
• Protect from light
• Do not freeze or shake
• To be sold by retail on the prescription of a Oncologist use only.

• Store at 2-8 degree C
• Do not freeze
• Do not shake
• Keep out of reach of children
• Keep the vial in outer carton in order to protect from light
• Not to be sold by retail without the prescription of a regsitered Medical Practioner.
• For IV use.

• Keep out of reach of children
• For intravenous administration after dilution
• Protect from light 
• 1 vial of 10 ml concentrate for solution for infusion
• Do not freeze or shake
• Before using check for absence of sediments
• To be sold by retail on the prescription of an Oncologist only.
• Do not accept if vial seal is broken

• Keep out of reach of children
• For intravenous administration after dilution
• Protect from light 
• 1 vial of 50 ml concentrate for solution for infusion
• Do not freeze or shake
• Before using check for absence of sediments
• To be sold by retail on the prescription of an Oncologist only.
• Do not accept if vial seal is broken

Biomab Injection (Nimotuzumab) is a monoclonal antibody therapy used in the treatment of head and neck cancers, glioma, and other epithelial cancers. It works by binding to the epidermal growth factor receptor (EGFR), blocking signals that stimulate cancer cell growth and survival. This targeted therapy helps slow disease progression, reduce tumor size, and improve overall treatment outcomes.

Manufactured under stringent pharmaceutical standards, Biomab Injection is trusted by oncologists worldwide for its safety, precision, and clinical effectiveness.

• Effective targeted therapy for head and neck squamous cell carcinoma

• Helps inhibit tumor growth and spread by blocking EGFR

• Can be used in combination with chemotherapy and radiotherapy

• Shown to improve treatment response and survival rates

• Well-tolerated with a lower risk of severe skin toxicity compared to similar agents

• Administered via intravenous infusion under medical supervision.

• Dosage and duration are determined by the oncologist based on the type and stage of cancer.

• Regular monitoring during therapy is recommended for best clinical outcomes.

• To be used only with a doctor’s prescription.

• Possible side effects: fever, chills, mild rash, nausea, or infusion-related reactions.

• Patients should inform their oncologist about any existing medical conditions, allergies, or concurrent medications.

• Treatment should be carried out in a specialized cancer care setting.

• Biomab Injection

• Biomab Nimotuzumab

• Biomab Injection uses

• Biomab Injection for head and neck cancer

• Biomab Injection dosage and side effects

• Buy Biomab Injection online

• EGFR monoclonal antibody for cancer

• Targeted therapy for head and neck cancer

• Store at 2-8 degree C
• Do not freeze
• Do not shake
• Keep out of reach of children
• Keep the vial in outer carton in order to protect from light
• Not to be sold by retail without the prescription of a regsitered Medical Practioner.
• For IV use.

• Each prefilled injection contains: Goserelin acetate equivalent to goserelin 10.8 mg peptide base in a long acting sustained release Implant.
• Contains one Implant in a prefilled Safesystem syringe with a protective sieeve.
• Use only if pouch is undamaged
• Use immediately after opening pouch
• Do not store above 25 degree C
• Keep all medicines away from children
• To be sold by retail on the prescription of a Registered Medical Practitioner only.

• Lyophilized for Intravenous use
• Dosage: As directed by the Oncologist.
• Storage: Store at a temperature below 25 degree C
• Protect from light 
• Keep out of reach of children
• To be sold by retail on the prescription of an Oncologist/Cancer Institution only.

• For subcutaneous injection
• Must be constituted before use
• Dosage: As directed by the Physician
• keep out of reach of children
• Do not use if solution is not clear or has suspended matter
• Not to be sold by retail on the prescription of a Registered Medical Practitioner.